Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Malignant Solid Tumour × dactolisib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Malignant Solid Tumour 1

Interventions

Vorinostat 2 pembrolizumab 1 nintedanib 1 dactolisib 1 avelumab 1 Vinorelbine 1 Sunitinib 1 Oxaliplatin 1 Levoleucovorin 1 Leucovorin 1 Hydroxychloroquine 1 Folfox protocol 1 Fluorouracil 1 Dasatinib 1 DOXO-EMCH 1 Cetuximab 1 Bevacizumab 1 BN 80927 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01343498 2015-05-01

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

SCRI Development Innovations, LLC

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡